title: [Surgical treatment of ovarian malignant tumors metastasized to the gastro-intestinal tract: a report of 131 cases].
abstract: OBJECTIVE
  To investigate the value and feasibility of surgical excision of gastro-intestinal metastatic tumors in patients with ovarian malignancy.
  
  
  METHODS
  The surgical and clinical data were retrospectively reviewed in 131 cases of ovarian malignant tumor with surgically excised gastrointestinal metastasis (> or = 2 cm in diameter).
  
  
  RESULTS
  Ovarian malignant tumor with gastro-intestinal metastasis accounted for 28.9% of the patients with primary ovarian malignancies in the same time period. Of the 131 cases, 126(93.9%) were in stage III and IV. The treatment was surgical excision combined with chemotherapy. Of the 141 operations, 83 (58.9%) were done by stripping of tumors on the gastro-intestinal wall and repair, 31(22.0%) received resection of the involved segment of the bowel with anastomosis, 27(19.2%) with colostomies. Postoperative complications occurred in 26.9% of the operated patients. The overall 2- and 5-year survival rate was 79.7% and 42.5%, respectively.
  
  
  CONCLUSIONS
  Surgical excision of gastro-intestinal tumors metastasized from primary ovarion malignancies is feasible to achieve cytoreduction. Prognosis can be improved when combined with chemotherapy.
authors.affiliation: Department of Obstetrics and Gynecology, Second Affiliated Hospital, West China University of Medical Sciences, Chengdu 610041.
authors.forename: Z
authors.initials: Z
authors.lastname: Peng
authors.forename: X
authors.initials: X
authors.lastname: Pan
authors.forename: H
authors.initials: H
authors.lastname: Liu
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D005260:Female; D005500:Follow-Up Studies; D005770:Gastrointestinal Neoplasms / Q000401:mortality / Q000473:pathology* / Q000556:secondary*; D006801:Humans; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D011183:Postoperative Complications; D015996:Survival Rate